Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 31 AL 45

Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect

Miguel-Álvarez M, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, Lucia A.

Drugs Aging. 2015 Feb;32(2):139-47. doi: 10.1007/s40266-015-0239-z.

Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease

Casamenti F, Grossi C, Rigacci S, Pantano D, Luccarini I, Stefani M.

J Alzheimers Dis. 2015;45(3):679-88. doi: 10.3233/JAD-142850.

The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease

Wright JW, Harding JW.

J Alzheimers Dis. 2015;45(4):985-1000. doi: 10.3233/JAD-142814.

Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis

Srinivasan M, Lahiri DK.

Expert Opin Ther Targets. 2015 Apr;19(4):471-87. doi: 10.1517/14728222.2014.989834. Epub 2015 Feb 4.

Retinoic acid as a therapeutic option in Alzheimer's disease: a focus on cholinergic restoration

Szutowicz A, Bielarczyk H, Jankowska-Kulawy A, Ronowska A, Pawełczyk T.

Expert Rev Neurother. 2015 Mar;15(3):239-49. doi: 10.1586/14737175.2015.1008456. Epub 2015 Feb 15.

Nanotherapeutic strategies for the treatment of Alzheimer's disease

Gu X, Chen H, Gao X.

Ther Deliv. 2015 Feb;6(2):177-95. doi: 10.4155/tde.14.97.

Design, synthesis and in vitro study of 5,6-diaryl-1,2,4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitors

Dadashpour S, Tuylu Kucukkilinc T, Unsal Tan O, Ozadali K, Irannejad H, Emami S.

Arch Pharm (Weinheim). 2015 Mar;348(3):179-87. doi: 10.1002/ardp.201400400. Epub 2015 Feb 18.

Building a roadmap for developing combination therapies for Alzheimer's disease

Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C.

Expert Rev Neurother. 2015 Mar;15(3):327-33. doi: 10.1586/14737175.2015.996551.

Neurostimulation in Alzheimer's disease: from basic research to clinical applications

Nardone R, Höller Y, Tezzon F, Christova M, Schwenker K, Golaszewski S, Trinka E, Brigo F.

Neurol Sci. 2015 May;36(5):689-700. doi: 10.1007/s10072-015-2120-6. Epub 2015 Feb 27.

Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease

Peter C, Braidy N, Zarka M, Welch J, Bridge W.

Curr Alzheimer Res. 2015;12(4):298-313. doi: 10.2174/1567205012666150302160308.

Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies

Arai H, Suzuki H, Yoshiyama T.

Curr Alzheimer Res. 2015;12(3):242-54. doi: 10.2174/1567205012666150302154121.

Growth factor treatment to overcome Alzheimer's dysfunctional signaling

Lauzon MA, Daviau A, Marcos B, Faucheux N.

Cell Signal. 2015 Jun;27(6):1025-38. doi: 10.1016/j.cellsig.2015.02.018. Epub 2015 Mar 3.

Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways

Bohm C, Chen F, Sevalle J, Qamar S, Dodd R, Li Y, Schmitt-Ulms G, Fraser PE, St George-Hyslop PH.

Mol Cell Neurosci. 2015 May;66(Pt A):3-11. doi: 10.1016/j.mcn.2015.02.016. Epub 2015 Mar 4.

Emerging drug targets for Aβ and tau in Alzheimer's disease: a systematic review

West S, Bhugra P.

Br J Clin Pharmacol. 2015 Aug;80(2):221-34. doi: 10.1111/bcp.12621. Epub 2015 Jun 8.

Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives

Tong LM, Fong H, Huang Y.

Exp Mol Med. 2015 Mar 13;47(3):e151. doi: 10.1038/emm.2014.124.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias